This site may receive compensation from the provider linked above. Full disclosure.
Weight loss and GLP-1 providers currently serving Cabell County, West Virginia — sourced from Google Business listings.
Weight loss service
1115 20th St, Huntington, WV 25703
Weight loss service
2399 US-60 #2, Huntington, WV 25705
Weight loss service
5269 Irwin Rd, Huntington, WV 25705
Business listings sourced from Google Maps. Information may not be current.
GLP-1 telehealth services are available to residents of all communities in Cabell County, West Virginia. Select your city for local information.
Cabell County is a county in West Virginia with a population of approximately 91,945 residents. Our telehealth platform connects patients across all communities in Cabell County with board-certified physicians who can prescribe FDA-approved GLP-1 medications online. West Virginia is the only state entirely within the Appalachian region, consistently ranking as one of the unhealthiest states in America. With 40.6% adult obesity and deep rural mountain communities where specialist care is hours away, GLP-1 telehealth is not a convenience but a lifeline.
GLP-1 receptor agonists — including semaglutide (Ozempic®, Wegovy®) and tirzepatide (Mounjaro®, Zepbound®) — are clinically proven weight loss medications. West Virginia's 40.6% adult obesity rate is the highest or second-highest in the US consistently. Over 17% of West Virginians have diagnosed diabetes. McDowell County has obesity rates exceeding 50%. Patients in Cabell County can now access these treatments through a simple online consultation, without the need to travel to an in-person clinic.
Access Ozempic, Wegovy, Mounjaro, and Zepbound — all FDA-approved GLP-1 medications proven to support significant weight loss in clinical trials.
All prescribing physicians in our network hold active West Virginia medical licenses. Consultations comply with West Virginia telehealth law (West Virginia Code § 30-3-13a).
Our simple 3-step process makes getting a GLP-1 prescription easy for Cabell County residents.
GLP-1 telehealth services are available across all West Virginia counties. Browse neighboring counties below.
Explore GLP-1 telehealth availability across West Virginia's major cities.
Yes. West Virginia law permits telehealth prescriptions for GLP-1 medications after a proper clinical evaluation under West Virginia Code § 30-3-13a. Our network of West Virginia-licensed physicians can complete your consultation online and send a prescription to your preferred pharmacy in Cabell County or arrange home delivery.
Patients in Cabell County can be prescribed semaglutide (Ozempic®, Wegovy®), tirzepatide (Mounjaro®, Zepbound®), and liraglutide (Saxenda®) — all FDA-approved GLP-1 receptor agonists indicated for weight management. Your physician will recommend the most appropriate option based on your health profile.
Consultation fees vary by provider, typically ranging from $0 to $199 for the initial visit. Medication costs depend on insurance coverage, manufacturer savings programs, and pharmacy choice. Many patients in West Virginia qualify for significant savings through patient assistance programs.
After completing your online health assessment, most patients in Cabell County receive a physician response within 24–48 hours. If approved, your prescription can be sent to a pharmacy near you in Cabell County or shipped directly to your home within 2–5 business days.
Cabell County has several local weight loss clinics and medical practices that may offer GLP-1 treatments in person. However, our telehealth service provides the same quality of care from the convenience of your home, with licensed West Virginia physicians available to patients throughout Cabell County.
Connect with experienced, US-licensed physicians specializing in metabolic health and GLP-1 therapy. All providers are board-certified and committed to evidence-based care.
Medically reviewed by
Dr. Sarah Mitchell, MD, ABOM
Board-Certified in Obesity Medicine • Last reviewed: June 5, 2026
Black Box Warning: In rodent studies, semaglutide and tirzepatide caused thyroid C-cell tumors. It is unknown whether GLP-1 receptor agonists cause thyroid C-cell tumors, including medullary thyroid carcinoma (MTC), in humans. These medications are contraindicated in patients with a personal or family history of MTC or Multiple Endocrine Neoplasia syndrome type 2 (MEN 2).
Common side effects may include nausea, vomiting, diarrhea, constipation, abdominal pain, headache, and injection site reactions. These typically diminish as dosage is gradually escalated.
Serious side effects may include pancreatitis, gallbladder problems, kidney injury, hypoglycemia (with insulin), and allergic reactions. Consult your healthcare provider immediately if you experience severe symptoms.
Contraindications: History of medullary thyroid carcinoma, MEN 2, pancreatitis, pregnancy or breastfeeding, severe gastrointestinal disease. This is not a complete list — always discuss your full medical history with your physician.
Clinical References:
